Semi-Annual Consolidated Statement Of Income

Kohjin Bio Co., Ltd. - Filing #7296611

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
2,507,586,000 JPY
2,507,586,000 JPY
1,101,203,000 JPY
JPY
629,614,000 JPY
776,768,000 JPY
Cost of sales
1,448,523,000 JPY
Gross profit (loss)
1,059,062,000 JPY
Ordinary profit (loss)
416,879,000 JPY
Extraordinary income
1,608,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
679,280,000 JPY
Extraordinary losses
51,693,000 JPY
Profit (loss) before income taxes
366,794,000 JPY
Operating profit (loss)
644,840,000 JPY
379,782,000 JPY
350,330,000 JPY
-265,057,000 JPY
190,773,000 JPY
103,735,000 JPY
Non-operating income
Interest income
524,000 JPY
Dividend income
84,000 JPY
Share of profit of entities accounted for using equity method
55,988,000 JPY
Non-operating income
65,851,000 JPY
Non-operating expenses
Interest expenses
14,325,000 JPY
Non-operating expenses
28,754,000 JPY
Income taxes
89,597,000 JPY
Profit (loss)
277,196,000 JPY
Extraordinary income
Gain on sale of non-current assets
1,608,000 JPY
Extraordinary losses
Profit (loss) attributable to owners of parent
277,196,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
383,000 JPY
Foreign currency translation adjustment
63,106,000 JPY
Other comprehensive income
63,490,000 JPY
Comprehensive income
340,686,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
340,686,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.